GLP-1 injections: Evidence and efficacy In contrast to patches, GLP-1 injections have extensive clinical evidence supporting their effectiveness: Clinical trial results Wegovy (semaglutide) : The STEP clinical trials involved thousands of participants and showed average weight loss of 15% after 68 weeks
BPC-157 is a synthetic pentadecapeptide derived from a fragment of a protective gastric protein and studied for its involvement in tissue-associated signaling pathways
What Can Be Done: Proactive Steps for Optimizing Results At Revitalizing Health and Hormones, we recommend a few logical steps based on what the research is beginning to show: Before starting GLP-1 or peptide therapy, get a complete health and medication historyincluding cholesterol meds (statins), hormone levels, and metabolic labs
For those ready to embrace this promising approach, a collaborative, holistic plan involving both medication and lifestyle changes is essential
This piece is an attempt to fill that gap, sourced from peer-reviewed literature rather than marketing copy